《JCM,2月26日,Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-01
  • Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review

    by Junxiong Pang 1,2,*,Min Xian Wang 1,2,Ian Yi Han Ang 1,Sharon Hui Xuan Tan 1,Ruth Frances Lewis 1,Jacinta I-Pei Chen 1,Ramona A Gutierrez 3,Sylvia Xiao Wei Gwee 1,2,Pearleen Ee Yong Chua 1,2,Qian Yang 1,Xian Yi Ng 1,Rowena KS Yap 1,Hao Yi Tan 1,Yik Ying Teo 1,Chorh Chuan Tan 4,Alex R. Cook 1,Jason Chin-Huat Yap 1 andLi Yang Hsu 1

    1

    Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117549, Singapore

    2

    Centre for Infectious Disease Epidemiology and Research, National University of Singapore, Singapore 117549, Singapore

    3

    National Centre for Infectious Diseases, Singapore 308442, Singapore

    4

    Ministry of Health, Singapore 169854, Singapore

    *

    Author to whom correspondence should be addressed.

    J. Clin. Med. 2020, 9(3), 623; https://doi.org/10.3390/jcm9030623

    Received: 13 February 2020 / Revised: 17 February 2020 / Accepted: 19 February 2020 / Published: 26 February 2020

    Abstract

    Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published.

  • 原文来源:https://www.mdpi.com/2077-0383/9/3/623
相关报告
  • 《SSRN,2月13日,Novel Coronavirus (2019-nCoV) Outbreak; A Systematic Review for Published Papers》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-02-14
    • Novel Coronavirus (2019-nCoV) Outbreak; A Systematic Review for Published Papers 23 Pages Posted: 13 Feb 2020 Adel Al-Gheethi Universiti Tun Hussein Onn Malaysia (UTHM) - Micropollutant Research Centre (MPRC) Efaq Noman Taiz University - Department of Applied Microbiology Qais Ali Al-Maqtari Jiangnan University - State Key Laboratory of Food Science and Technology Kamal Hezam Taiz University - Department of Applied Microbiology Radin Mohamed Universiti Tun Hussein Onn Malaysia (UTHM) - Micropollutant Research Centre (MPRC) Balkis Talip Universiti Tun Hussein Onn Malaysia (UTHM) - Faculty of Applied Sciences and Technology Norli Ismail Universiti Sains Malaysia (USM) - Environmental Technology Division Abstract The novel coronavirus (2019-nCoV) outbreak has been traced in China late 2019 and then was transmitted into more than 25 countries. A total of 49 papers have been published in 20 journals during the last January and current February. These papers tried to explain the source of virus, the transmission route, genomic map and the similarity to previous viruses as well as the pathogenesis, symptoms and treatment methods. The huge numbers of the articles which were published on 2019-nCoV make confusing for the readers, since many of the articles are addressed similar topics. In this paper a systematic analysis was conducted for the published articles. The finding of these papers were summarized. Moreover, the present paper aim to highlight the responses of scientists and Journals for the 2019-nCoV outbreak. This paper reviewed 49 peer viewed articles while hundreds article still in the preprint. It was appeared that the Lancet journal has the highest numbers of publications (29%) which given an early alarm for 2019-nCoV. The first paper suggested Baricitinib as potential treatment for 2019-nCoV acute respiratory disease was published on 3 February in the Lancet Journal. In 16 January 2020, the genomic characteristics of the virus was published, followed by several papers on the diagnostic of the virus, pathogenicity and symptoms was more clear on 29 January. The Nature Journal was the fist which given an alarm for the 2019-nCoV outbreak. In conclusion source of 2019-nCoV, treatment methods, as well as vaccines, pathogenicity of the virus in the patient with HIV or other virus infections, transmission to fetus in the pregnant women still need more investigation.
  • 《LANCET,2月7日,Pandemic potential of 2019-nCoV》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-09
    • Pandemic potential of 2019-nCoV Robin Thompson Published:February 07, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30068-2 An important determinant of whether or not 2019 novel coronavirus (2019-nCoV) will ultimately cause a global pandemic is its ability to become established upon its importation to a new country. Cases of 2019-nCoV infection have so far been reported in 24 countries, yet little human-to-human transmission outside of China has occurred.